News
ALLHAT Press Release
Diuretics were associated with reduced heart disease in a drug comparison trial involving 23,077 people with both high blood pressure and the metabolic syndrome...[Read More]
GenHAT Press Release
Genetic makeup may impact the effectiveness of medications for high blood pressure, which could help explain why certain drugs work for some people and not for others...[Read More]
ALLHAT Press Release
"Landmark Hypertension Treatment Study Launches Extensive Physician and Patient Education Program to Improve Public Health" (from NIH/NHLBI). Researchers in the largest high blood pressure clinical trial ever conducted are launching a comprehensive outreach program to improve high blood pressure control nationwide. . . [Read more]
ALLHAT Publication
Three University of Texas School of Public Health at Houston faculty members are co-authors of , "Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril,"which has just been published (The Journal of the American Medical Association (2005;293:1595-1607). This article reports study results suggesting older, cheaper diuretics remain the drug of choice for both black and nonblack patients in treating high blood pressure and reducing risk of heart disease.
The multicenter ALLHAT study is conducted under a National Institutes of Health contract with The University of Texas Health Science Center at Houston. The co-authors are all faculty in the UTSPH Division of Biostatistics and the Coordinating Center for Clinical Trials. They are J. Kay Dunn, Ph.D., associate professor, Barry R. Davis, M.D., Ph.D., professor and director, and Charles E. Ford, Ph.D., associate professor.
CCCT Director Receives President's Scholar Award
Barry R. Davis, M.D., Ph.D., professor and director of the Division of Biostatistics and director of the CCCT at the UT School of Public Health at Houston, received the 2004 President's Scholar Award for research. [Read more]
ALLHAT Publication
A new article, "ALLHAT: Setting the Record Straight,"has just been published (Annals of Internal Medicine (2004;141:39-46).
ALLHAT News
UTHSC-H Distinctions (May 2004) identifies the public information campaign that will use 200 clinician-educators to meet with physicians and professional organizations nationwide in "Project Goes 'Door to Door' To Promote Blood Pressure Treatment News."
KUHF Houston Public Radio (April 6, 2004) reported on the campaign to inform physicians about the ALLHAT study and its recommendations in the Real Audio sound file, "New Development in the Treatment of Hypertension".
The Houston Chronicle (February 28, 2004) discusses an unprecedented initiative by NHLBI to disseminate ALLHAT study results in "Fed Ads Touting Cheaper Drugs / Diuretics Study Done Here Details Benefits for Hypertension."
ETROP Results Released!
Premature infants will retain better vision when therapy is administered in the early stage of the disease. [Read more]
